Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
![]() |
DNA plasmid HIV vaccine design, number of doses, participant gender, and body mass index affect T-cell responses across HIV vaccine clinical trialsMorgan, C ; Jin, X ; Yu, X ; De Rosa, S ; Kublin, J ; Metch, B ; Keefer, M ; NIAID, HRetrovirology, 2012-09, Vol.9 (S2), p.P133-P133, Article P133 [Periódico revisado por pares]London: BioMed CentralTexto completo disponível |
2 |
Material Type: Artigo
|
![]() |
Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest Oncology Group studyFORASTIERE, AA ; METCH, B ; SCHULLER, DE ; ENSLEY, JF ; HUTCHINS, LF ; TRIOZZI, P ; KISH, JA ; MCCLURE, S ; VONFELDT, E ; WILLIAMSON, SK ; VONHOFF, DDJournal of clinical oncology, 1992-08, Vol.10 (8), p.1245-1251 [Periódico revisado por pares]ALEXANDRIA: American Society of Clinical OncologySem texto completo |
3 |
Material Type: Artigo
|
![]() |
Feasibility of recruiting high-risk women in the US for HIV vaccine efficacy trials (HVTN 906)Koblin, B ; Metch, B ; Morgan, C ; Novak, R ; Swann, E ; Metzger, D ; Lucy, D ; Dunbar, D ; Graham, P ; Madenwald, T ; Escamia, G ; Frank, IRetrovirology, 2012-09, Vol.9 (S2), p.P123-P123, Article P123 [Periódico revisado por pares]London: BioMed CentralTexto completo disponível |
4 |
Material Type: Artigo
|
![]() |
P15-08. Did unblinding affect HIV risk behaviour and risk perception in the HVTN503/Phambili study?Gray, GE ; Bekker, L ; Churchyard, G ; Nchabeleng, M ; Mlisana, K ; de Bruyn, G ; Roux, S ; Mathebula, M ; Latka, M ; Bennie, T ; Metch, B ; Moodie, Z ; Allen, M ; Eaton, N ; Kublin, JRetrovirology, 2009-10, Vol.6 (Suppl 3), p.P209-P209, Article P209 [Periódico revisado por pares]BioMed Central LtdTexto completo disponível |
5 |
Material Type: Artigo
|
![]() |
P14-02. Social impact events in Phambili, the first phase 2B HIV vaccine trial in South AfricaAllen, MA ; Gray, G ; Churchyard, G ; Bekker, L ; Nchabeleng, M ; Mlisana, K ; Metch, B ; Moodie, Z ; Roux, S ; Mathebula, M ; Bennie, T ; Kublin, JRetrovirology, 2009-10, Vol.6 (Suppl 3), p.P190-P190, Article P190 [Periódico revisado por pares]London: BioMed CentralTexto completo disponível |
6 |
Material Type: Artigo
|
![]() |
P14-07. Offering new prevention modalities in HIV vaccine trials: experience with male circumcision in the Phambili trialde Bruyn, G ; Mlisana, K ; Metch, B ; Churchyard, G ; Nchabeleng, M ; Bekker, L ; Roux, S ; Naicker, N ; Latka, M ; Corey, L ; Kublin, J ; Gray, GRetrovirology, 2009-10, Vol.6 (S3), p.P195-P195, Article P195 [Periódico revisado por pares]London: BioMed CentralTexto completo disponível |
7 |
Material Type: Artigo
|
![]() |
Adjuvant CMFVP versus tamoxifen versus concurrent CMFVP and tamoxifen for postmenopausal, node-positive, and estrogen receptor-positive breast cancer patients: a Southwest Oncology Group studyRivkin, S E ; Green, S ; Metch, B ; Cruz, A B ; Abeloff, M D ; Jewell, W R ; Costanzi, J J ; Farrar, W B ; Minton, J P ; Osborne, C KJournal of clinical oncology, 1994-10, Vol.12 (10), p.2078-2085 [Periódico revisado por pares]United States: American Society of Clinical OncologySem texto completo |
8 |
Material Type: Artigo
|
![]() |
Adjuvant CMFVP versus melphalan for operable breast cancer with positive axillary nodes: 10-year results of a Southwest Oncology Group StudyRivkin, S E ; Green, S ; Metch, B ; Glucksberg, H ; Gad-el-Mawla, N ; Constanzi, J J ; Hoogstraten, B ; Athens, J ; Maloney, T ; Osborne, C KJournal of clinical oncology, 1989-09, Vol.7 (9), p.1229-1238 [Periódico revisado por pares]United States: American Society of Clinical OncologySem texto completo |
9 |
Material Type: Artigo
|
![]() |
Prognostic significance of progesterone receptor levels in estrogen receptor-positive patients with metastatic breast cancer treated with tamoxifen: results of a prospective Southwest Oncology Group studyRAVDIN, PM ; GREEN, S ; DORR, TM ; MCGUIRE, WL ; FABIAN, C ; PUGH, RP ; CARTER, RD ; RIVKIN, SE ; BORST ; BELT, RJ ; METCH, B ; OSBORNE, CKJournal of clinical oncology, 1992-08, Vol.10 (8), p.1284-1291 [Periódico revisado por pares]ALEXANDRIA: American Society of Clinical OncologySem texto completo |
10 |
Material Type: Artigo
|
![]() |
Quality of life assessment in Southwest Oncology Group trialsMoinpour, C M ; Hayden, K A ; Thompson, I M ; Feigl, P ; Metch, BOncology (Williston Park, N.Y.), 1990-05, Vol.4 (5), p.79-84 [Periódico revisado por pares]United StatesSem texto completo |